v3.26.1
Consolidated Statements of Convertible Preferred Stock and Stockholders’ Deficit - USD ($)
$ in Thousands
Total
Series F Convertible Preferred Stock warrants
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Convertible Preferred Stock
Convertible Preferred Stock
Series F Convertible Preferred Stock warrants
Convertible Preferred Stock Held by Consolidated VIE
Beginning balance (in shares) at Dec. 31, 2022             209,613,570   (51,247,915)
Beginning balance at Dec. 31, 2022             $ 322,748   $ (2,381)
Ending balance (in shares) at Dec. 31, 2023             209,613,570   (51,247,915)
Ending balance at Dec. 31, 2023             $ 322,748   $ (2,381)
Beginning balance (in shares) at Dec. 31, 2022     79,465,150            
Beginning balance at Dec. 31, 2022 $ (348,006)   $ 267 $ (23,417) $ 158,814 $ (483,670)      
Beginning balance (in shares) at Dec. 31, 2022       (5,177,235)          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of vested stock options (in shares)     2,637,479            
Exercise of vested stock options 117   $ 26   91        
Stock-based compensation expense 1,804       1,804        
Net Loss (106,462)         (106,462)      
Ending balance (in shares) at Dec. 31, 2023     82,102,629            
Ending balance at Dec. 31, 2023 $ (452,547)   $ 293 $ (23,417) 160,709 (590,132)      
Ending balance (in shares) at Dec. 31, 2023       (5,177,235)          
Ending balance (in shares) at Dec. 31, 2024 209,613,570           209,613,570   (51,247,915)
Ending balance at Dec. 31, 2024             $ 322,748   $ (2,381)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of vested stock options (in shares)     540,055            
Exercise of vested stock options $ 18   $ 7   11        
Stock-based compensation expense 1,923       1,923        
Net Loss $ (54,079)         (54,079)      
Ending balance (in shares) at Dec. 31, 2024 77,465,449   82,642,684            
Ending balance at Dec. 31, 2024 $ (504,685)   $ 300 $ (23,417) 162,643 (644,211)      
Ending balance (in shares) at Dec. 31, 2024       (5,177,235)          
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Exercise of Series F convertible preferred stock warrant (in shares)               51,614,124  
Exercise of Series F convertible preferred stock warrant (Note 13)               $ 73,808  
Ending balance (in shares) at Dec. 31, 2025 261,227,694 51,614,127         261,227,694   (51,247,915)
Ending balance at Dec. 31, 2025             $ 396,556   $ (2,381)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of vested stock options (in shares)     737,326            
Exercise of vested stock options $ 47   $ 7   40        
Stock-based compensation expense 1,557       1,557        
Net Loss $ (35,702)         (35,702)      
Ending balance (in shares) at Dec. 31, 2025 78,202,775   83,380,010            
Ending balance at Dec. 31, 2025 $ (538,783)   $ 307 $ (23,417) $ 164,240 $ (679,913)      
Ending balance (in shares) at Dec. 31, 2025       (5,177,235)